110.   We would like to recall our previous statements on these items. As indicated previously, in this discussion we often lose the relative importance of the individual components making up the 'Triplets'. The Doha Ministerial Declaration instructed the TRIPS Council as part of its work programme to review Article 27.3(b) as well as examine the relationship between the TRIPS Agreement and the Convention on Biological Diversity (CBD) and the protection of traditional knowledge and folklore. These are important mandated issues which remain an integral part of the Doha round single undertaking. 111.   Biopiracy remains a pervasive problem and in the absence of a multilateral solution, as applicable under the TRIPS Agreement, national disclosure requirements will remain inadequate. It is encouraging that WIPO is making progress in the area of genetic resources, and we would urge that the WTO does not make this another area of interest to developing countries, where we adopt a siloed and non-responsive approach. 112.   Discussions in this forum and those under the auspices of the IGC at WIPO are complimentary and not mutually exclusive. In this regard, we welcome the progress made at the recent WIPO General Assembly where consensus was reached on a diplomatic conference dealing with genetic resources. The WTO membership should certainly take note of such developments. As indicated previously, our delegation would welcome a briefing from WIPO in this regard. Similarly, it would be useful for the CBD Secretariat to brief the TRIPS Council on the CBD and other implementation issues under the Nagoya Protocol as well as any new developments. 113.   We also wish to raise once more the issue of the update of the three technical notes contained in documents IP/C/W/368/Rev.1, IP/C/W/369/Rev.1 and IP/C/W/370/Rev.1. It would be appropriate for the Secretariat to update the information contained in these notes in a neutral manner to further facilitate discussions among Members. 114.   Finally, we are concerned about the lack of progress on issues of interest to developing countries due to the blockage of discussions by a few Members. This does not augur well for a system that is balanced and is expected to address the interests of all. We would like to suggest that we revive our discussions by encouraging Members to share experiences on how they regulate R&D on genetic resources, what measures they have put in place to incentivize benefit-sharing between the providers and the user prior to access, mechanisms that have been put in place to strengthen the ability of indigenous people and local communities to benefit from the use of traditional knowledge, and measures implemented to promote technology transfer and cooperation to build research and innovation capacity in developing countries, among others.